DrugPatentWatch Database Preview➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing
« Back to Dashboard
Heparin Sodium is a drug marketed by Abraxis Pharm, Akorn, B Braun Medical Inc, Be Pharms, Casi Pharms Inc, Chamberlin Parenterl, Dell Labs, Dr Reddys, Fresenius Kabi Usa, Gland Pharma Ltd, Hikma, Hospira, Hospira Inc, Lilly, Luitpold, Mylan Labs Ltd, Nanjing King-friend, Organon Usa Inc, Parke Davis, Pfizer, Pharm Spec, Pharmacia And Upjohn, Sagent Pharms, Sandoz, Shenzhen Techdow, Smith And Nephew, Solopak, Watson Labs Inc, West-ward Pharms Int, Baxter Hlthcare, Mcgaw, B Braun, and Pharma Serve Ny. and is included in sixty-nine NDAs.
The generic ingredient in HEPARIN SODIUM is heparin sodium. There are seventy-seven drug master file entries for this compound. Sixteen suppliers are listed for this compound. Additional details are available on the heparin sodium profile page.
A generic version of HEPARIN SODIUM was approved as heparin sodium by HOSPIRA on April 28th, 1983.
Summary for HEPARIN SODIUM
|Finished Product Suppliers / Packagers:||13|
|Formulation / Manufacturing:||see details|
|Drug Prices:||Drug price information for HEPARIN SODIUM|
|What excipients (inactive ingredients) are in HEPARIN SODIUM?||HEPARIN SODIUM excipients list|
|DailyMed Link:||HEPARIN SODIUM at DailyMed|
Recent Clinical Trials for HEPARIN SODIUM
Identify potential brand extensions & 505(b)(2) entrants
|Johns Hopkins University||Phase 4|
|Cairo University||Phase 4|
|Guangdong Provincial People's Hospital||N/A|